Paper35014759
Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.
O'Byrne LJ and 6 others. BJOG, 2022. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis. Papers, record 35014759. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35014759
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Premature Birth | Major topic |
| Cross-Sectional Studies | |
| Female | |
| Humans | |
| Infant, Newborn | |
| Pregnancy | |
| Pregnancy Outcome | |
| Prenatal Care |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| UCB pharma | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 35015341 | Systematic reviews and meta-analyses: Bigger is not necessarily better. | https://conductscience.org/library/papers/35015341 |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16855148 | Epidemiological aspects of rheumatoid arthritis: the sex ratio. | Ann N Y Acad Sci | 2006 | https://conductscience.org/library/papers/16855148 | PubMed |
| 2 | 24284028 | Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. | Reprod Toxicol | 2014 | https://conductscience.org/library/papers/24284028 | PubMed |
| 3 | 29961692 | Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy. | J Rheumatol | 2018 | https://conductscience.org/library/papers/29961692 | PubMed |
| 4 | 17185356 | A meta-analysis on the influence of inflammatory bowel disease on pregnancy. | Gut | 2007 | https://conductscience.org/library/papers/17185356 | PubMed |
| 5 | 25966992 | Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety. | Gut | 2016 | https://conductscience.org/library/papers/25966992 | PubMed |
| 6 | 33046558 | Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life. | Gut | 2021 | https://conductscience.org/library/papers/33046558 | PubMed |
| 7 | 24980270 | Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease. | Aliment Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24980270 | PubMed |
| 8 | 33227283 | Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. | Gastroenterology | 2021 | https://conductscience.org/library/papers/33227283 | PubMed |
| 9 | 29771301 | Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type. | J Crohns Colitis | 2018 | https://conductscience.org/library/papers/29771301 | PubMed |
| 10 | 30078176 | A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences. | Adv Ther | 2018 | https://conductscience.org/library/papers/30078176 | PubMed |
| 11 | 29771477 | Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study. | Arthritis Rheumatol | 2018 | https://conductscience.org/library/papers/29771477 | PubMed |
| 12 | 30231982 | Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development. | Immunity | 2018 | https://conductscience.org/library/papers/30231982 | PubMed |
| 13 | 32118278 | Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/32118278 | PubMed |
| 14 | 19621072 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | PLoS Med | 2009 | https://conductscience.org/library/papers/19621072 | PubMed |
| 15 | 31692017 | Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. | Aliment Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31692017 | PubMed |
| 16 | 26873562 | Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan. | Mod Rheumatol | 2016 | https://conductscience.org/library/papers/26873562 | PubMed |
| 17 | 28858070 | Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight. | Inflamm Bowel Dis | 2017 | https://conductscience.org/library/papers/28858070 | PubMed |
| 18 | 19577836 | Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. | Eur J Obstet Gynecol Reprod Biol | 2009 | https://conductscience.org/library/papers/19577836 | PubMed |
| 19 | 35014759 | Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis. | BJOG | 2022 | https://conductscience.org/library/papers/35014759 | PubMed |
| 20 | 29496718 | Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study. | Ann Rheum Dis | 2018 | https://conductscience.org/library/papers/29496718 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42766183 | Therapeutics Beyond Delivery: Repurposed Drugs and Biologic Pathways. | Curr Hypertens Rep | 2026 | https://conductscience.org/library/papers/42766183 | PubMed |
| 42650751 | Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650751 | PubMed |
| 42387357 | The Asia Pacific League of Associations for Rheumatology (APLAR) Consensus Statements for the Management of Reproductive Issues in Autoimmune Rheumatic Diseases. | Int J Rheum Dis | 2026 | https://conductscience.org/library/papers/42387357 | PubMed |
| 42271552 | Systemic lupus erythematosus and pregnancy: a comprehensive clinical review of maternal, fetal, and treatment considerations. | Adv Rheumatol | 2026 | https://conductscience.org/library/papers/42271552 | PubMed |
| 41822811 | The Role of Complement and CD4 T Cells in Preeclampsia and Offspring Neurodevelopment. | Curr Opin Physiol | 2026 | https://conductscience.org/library/papers/41822811 | PubMed |
| 41021022 | Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework. | Rheumatol Int | 2025 | https://conductscience.org/library/papers/41021022 | PubMed |
| 39812078 | Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol. | Int J Rheum Dis | 2025 | https://conductscience.org/library/papers/39812078 | PubMed |
| 39699934 | Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One-year outcomes from the international noninterventional CIMREAL study. | J Eur Acad Dermatol Venereol | 2025 | https://conductscience.org/library/papers/39699934 | PubMed |
| 38690936 | TNF-α inhibitor use during pregnancy and the risk of preeclampsia: population-based cohort study. | J Hypertens | 2024 | https://conductscience.org/library/papers/38690936 | PubMed |
| 38202041 | Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review. | J Clin Med | 2023 | https://conductscience.org/library/papers/38202041 | PubMed |
| 37973775 | Effect of Anti-TNF Biologic Exposure During Pregnancy on Villitis of Unknown Etiology Diagnoses in Patients with Autoimmune Disease. | Reprod Sci | 2024 | https://conductscience.org/library/papers/37973775 | PubMed |
| 37272561 | Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases. | J Korean Med Sci | 2023 | https://conductscience.org/library/papers/37272561 | PubMed |
| 35693803 | Case Report: TNF-Alpha Inhibitors to Rescue Pregnancy in Women With Potential Pregnancy Loss: A Report of Ten Cases. | Front Immunol | 2022 | https://conductscience.org/library/papers/35693803 | PubMed |
| 35014759 | Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis. | BJOG | 2022 | https://conductscience.org/library/papers/35014759 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35014759
GET https://conductscience.org/api/papers/v1/35014759/references?page=2